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Christian Freund*[a] and Dirk Schwarzer*[b]
The transpeptidase sortase A of Staphylococcus aureus (Sa-SrtA)
is a valuable tool in protein chemistry. The native enzyme
anchors surface proteins containing a highly conserved LPxTG
sorting motif to a terminal glycine residue of the peptidoglycan
layer in Gram-positive bacteria. This reaction is exploited for
sortase-mediated ligation (SML), allowing the site-specific link-
age of synthetic peptides and recombinant proteins by a native
peptide bond. However, the moderate catalytic efficiency and
specificity of Sa-SrtA fueled the development of new biocata-
lysts for SML, including the screening of sortase A variants form
microorganisms other than S. aureus and the directed protein
evolution of the Sa-SrtA enzyme itself. Novel display platforms
and screening formats were developed to isolate sortases with
altered properties from mutant libraries. This yielded sortases
with strongly enhanced catalytic activity and enzymes recogniz-
ing new sorting motifs as substrates. This minireview focuses on
recent advances in the field of directed sortase evolution and
applications of these tailor-made enzymes in biochemistry.
1. Introduction
Bacterial transpeptidases have gained considerable attention as
promising tools in modern biochemistry and biotechnology.
Sortase A of Staphylococcus aureus is the most widely used class
of transpeptidase employed for bioconjugation and seminsyn-
thesis of proteins.[1] In bacteria, sortase A is inserted into the
bacterial cell wall and cross-bridges surface proteins to the
peptidoglycan, facilitating bacterial evasion of the host’s
immune system.[2] The enzyme recognizes a sorting motif
LPxTG, (with x=any amino acid) in the C-terminal region of the
surface protein, and cleaves this sequence at the threonine
residues.[3] Upon cleavage, the peptide chain downstream of
the threonine residue is released as leaving group, while the
upstream fragment remains tethered to the active site cysteine
as threonine-thioester (Figure 1a).[4] In the following, the
enzyme is deacylated by ligating the sortase-bound thioester to
the N-terminal amino group of the pentaglycine moiety located
at the peptidoglycan cross-bridge. Two features render sortases
attractive tools for protein chemistry: The membrane anchor
can be removed from the enzyme without loss of trans-
peptidase activity, and resulting N-terminal truncated enzymes
are soluble.[5] Furthermore, the LPxTG motif and N-terminal
glycine moieties are sufficient as sortase A substrates, with two
glycines minimally required for full activity of the wild-type
enzyme. Upon incorporation of the sorting motif and N-
terminal glycine into two separate peptides or proteins, sortase
A is capable of ligating the two fragments.[6] This methodology,
also referred to as sortase-mediated ligation (SML) or “sortag-
ging,” is widely applied in modern biochemistry (Figure 1a).[7]
Up to date sortase A of S. aureus lacking the N-terminal
membrane anchor (Sa-SrtA) is the most widely used enzyme for
SML. However, SML catalyzed by Sa-SrtA also suffers from
shortcomings hampering broader applications. The reversibility
of SML takes a toll on ligation yields, but engineering of sortase
substrates by installation of depsipeptide bonds into the sorting
motif, inducing secondary structural elements or metal-assisted
SML provide efficient strategies for addressing this problem.[8]
The main downsides of the catalyst – wild-type Sa-SrtA – are
the high KM value for the sorting motif, poor catalytic activity, a
narrow specificity range for the LPxTG sorting motif, and the
requirement of calcium as a cofactor.[3] Researchers have
recently started addressing these issues by investigating
previously uncharacterized sortases from other microorganisms
and by directed evolution of Sa-SrtA. While these developments
are still ongoing, successful engineering of Sa-SrtA has been
reported over the last ten years, representing the central focus
of this minireview.
2. Natural Sortase Variants
Sa-SrtA served as the model enzyme for uncovering the
function and activity of sortases in bacteria and belongs to the
class A sortases. In addition to the class A enzymes, sortases of
classes B-F have been identified, which differ in function and
specificity from Sa-SrtA.[9] For example, sortase B of S. aureus
(Sa-SrtB) recognizes an NPxTG motif and is involved in bacterial
iron uptake.[10] However, several sortases of classes B-F show
limited activity in vitro and are not commonly used for SML.
Consequently, research on new catalysts of SML has focused
mainly on class A sortases based on the assumptions that
enzymes from other bacteria might reveal altered substrate
[a] Prof. Dr. C. Freund
Freie Universität Berlin, Institute of Chemistry and Biochemistry
Thielallee 63, 14195 Berlin (Germany)
E-mail: chfreund@zedat.fu-berlin.de
[b] Prof. Dr. D. Schwarzer
University of Tübingen, Interfaculty Institute of Biochemistry (IFIB)
Auf der Morgenstelle 34, 72076 Tübingen (Germany)
E-mail: dirk.schwarzer@uni-tuebingen.de
This article is part of a joint Special Collection with the Journal of Peptide
Science on SPP 1623: Chemoselective reactions for the synthesis and ap-
plication of functional proteins. Please see our homepage for more articles in
the collection.
© 2020 The Authors. ChemBioChem published by Wiley-VCH GmbH. This is
an open access article under the terms of the Creative Commons Attribution
Non-Commercial License, which permits use, distribution and reproduction





1347ChemBioChem 2021, 22, 1347 – 1356 © 2020 The Authors. ChemBioChem published by Wiley-VCH GmbH
Wiley VCH Dienstag, 13.04.2021
2108 / 192279 [S. 1347/1356] 1
specificity. The pentaglycine unit at the peptidoglycan cross-
bridge deacylates Sa-SrtA bound thioesters in S. aureus, but this
peptide nucleophile varies with the compositions of
peptidoglycan.[2,5,11] For example, the peptidoglycan cross-
bridge of Streptococcus pyogenes harbors a terminal alanine,
serine, or glycine residue.[12] The corresponding S. pyogenes
sortase A (Sp-SrtA) was shown to ligate the enzyme-bound
thioesters to N-Ala nucleophiles (Figure 1b). This distinct
specificity of Sp-SrtA could be exploited for a dual ligation
scheme when combined with Sa-SrtA.[13]
Recent investigations aimed to explore the potential of
previously uncharacterized class A sortases from various
bacteria on a larger scale.[14] Focusing on the enzymes of
Staphylococcus and Streptococcus origin, several sortase A genes
were cloned, expressed, and the enzymes characterized with
libraries of putative substrate peptides. These investigations
uncovered that several Streptococcus sortases display a much
more promiscuous substrate specificity than the Sa-SrtA. The
experiments confirmed that Streptococcus sortases accept a
broader range of substrates including LPxTG, LPxTA, and LPxTS
motifs and N-Gly, N-Ala, and N-Ser nucleophiles.[14] In addition,
alternative transacylation sites have been detected for some of
these enzymes.[14a] Furthermore, the majority of investigated
Streptococcus enzymes show a strong preference for an
alternative LPxLG sorting motif, which is ligated more efficiently
than the canonical LPxTG sorting motif in vitro.[14b]
A further promising enzyme for protein chemistry is sortase
A of C. diphtheriae (Cd-SrtA). This enzyme is responsible for pilin
polymerization in this bacterium. The deacylating amine
nucleophile in Cd-SrtA catalyzed ligations is not the N-terminal
residue of a peptidoglycan cross-bridge, but an internal lysine
residue in pilin subunit SpaA. Pilin polymerization occurs by Cd-
SrtA catalyzed crosslinking of a C-terminal LPLTG sequence in
CSpaA to the internal lysine moiety in a neighboring NSpaA
protein (Figure 1c). In vitro transpeptidase activity of Cd-SrtA
could be established by introducing two mutations into an N-
terminal lid extension of the enzyme that otherwise blocks the
active site.[15] Introduction of three further mutations resulted in
the Cd-SrtA-M3 enzyme that requires the internal lysine of SpaA
as the ligation site and peptides with C-terminal LPLTG
extension.[16] Protein bioconjugation with Cd-SrtA-M3 was then
established by fusing SpaA to a protein of interest, followed by
SML with synthetic LPLTG containing peptides. Importantly, Cd-
SrtA-M3 and Sa-SrtA ligation schemes can be combined for dual
labeling strategies when the protein of interest is fused to SpaA
and contains an additional N-terminal glycine extension.
These investigations demonstrate that natural sortases
possess new and useful features for SML. Given the number of
sortase A sequences deposited in gene repositories, it appears
likely that further investigative endeavors into the pool of
uncharacterized sortases will uncover new biocatalysts with
advantageous properties for SML (Table 1).
3. Engineering of Sortases
Sortase engineering is a highly promising strategy for establish-
ing new biocatalysts optimized for the needs of SML
approaches. Such tailor-made sortases with engineered features
have been generated by directed protein evolution.
Figure 1. Sortases and sortase-mediated ligation (SML). a) Sortase A of S.
aureus (Sa-SrtA) recognizes LPxTG sorting motifs as substrates and cleaves
this sequence at the threonine residue with formation of a sortase-bound
thioester. The downstream peptide with N-terminal glycine residue is
released from the enzyme. The thioester is resolved by ligation to a peptide
nucleophile with at least two glycine residues at the N terminus. b) Native
sortases install surface proteins to the bacterial peptidoglycan cross-bridge.
In the case of S. aureus, the cross-bridge contains a pentaglycine moiety as
the nucleophile, while the peptidoglycan of S. pyogenes provides an N-
terminal alanine residue for the ligation reaction. The composition of the
bacterial peptidoglycan impacts sortase substrate specificity. c) Sortase A of
Corynebacterium diphtheriae catalyzes isopeptide formation at an internal
lysine of SpaA with a C-terminal sorting motif from a neighboring SpaA
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3.1. Engineered Sa-SrtA mutants with enhanced kinetics
Sa-SrtA possesses low catalytic activity as result of a high KM of
5 mM for the LPxTG substrate and a turnover rate of 1 s  1.[3] The
high KM in the millimolar range is a major obstacle for SML
approaches and might be explained by the fact that native Sa-
SrtA, which includes a membrane anchor, operates at high local
concentrations of both substrates, which are also bound to the
bacterial cell wall. Consequently, the evolutionary pressure on
high substrate affinity might have been low. The lack of high
local substrate concentrations in SML has been addressed by
the development of proximity-based SML.[17] Sortase and LPxTG
containing substrate proteins are tethered together by the
SpyCatcher-SpyTag peptide-protein pair in this approach,
resulting in accelerated ligation rates.[18]
However, protein evolution is a highly promising alternative
approach for addressing this problem by enhancing the kinetics
of the catalyst itself. In order to evolve more active Sa-SrtA
mutants, an elaborated yeast display system for selecting
sortase mutants with enhanced kinetics was established.
Sortase mutants are displayed on the surface of yeast cells as
fusion proteins with mating factor Aga2p, while the genetic
information is stored in the cell. The Aga2p-mut-SrtA fusion is
disulfide-linked to a second protein, Aga1p, which can be
equipped with a peptide nucleophile by bioconjugation
employing a glycine functionalized S6 tag. Conjugation of the
S6 tag requires the coenzyme A (CoA) triglycine substrate and
4’-phosphopantethein transferase Sfp as catalyst. Upon installa-
tion of a triglycine nucleophile at Aga1p, bound SrtA was
shown to ligate biotin-LPxTG peptides to the triglycine














Sa-SrtA LPxTG N-Gly-Gly yes
Sp-SrtA LPxLG N-Ala-Ala - no LPxTG, LPxTA donors and
N-Gly-Gly, N-Ala-Gly,
N-Ser-Gly acceptors are
further substrates of Sp-SrtA
[14]
Cd-SrtA LPLTG Internal Lys
of SpaA
n.d. no [16]
Sortase mutants with enhanced activity
SrtA-M4 LPxTG N-Gly-Gly + + yes kcat/KM (LPETG)= 28.000 M
  1 s  1
compared to 200 M  1 s  1
for wt. 9.3-fold lower kcat/KM
(GGG)
[19]
SrtA-M5 LPxTG N-Gly-Gly + + yes kcat/KM (LPETG)= 23.000 M
  1 s  1
compared to 200 M  1s  1
for wt. 5.8-fold lower kcat/KM
(GGG)
[19]
SrtA-M7 LPxTG N-Gly-Gly + + no kcat/KM (LPETG)= 5.780 M
  1s  1
in the absence of Ca2 +
[23]
SrtA-M5/D124G LPxTG N-Gly-Gly + + yes SML at antibody N termini;
kcat/KM (LPETG)= 9.305 M
  1s  1
compared to 159 M  1s  1 for wt.
[20]
SrtA-M5/D124G/Y187L/E189R LPxTG N-Gly-Gly + + yes SML at antibody C termini:
kcat/KM (LPETG)= 16.722 M
  1s  1.
[20]
SrtA-M4/R159N/K162P LPxTG N-Gly-Gly + + yes increased thermostability of M4 [37]
SrtA-P94H/A104T/E105D/G167E/Q172H LPxTG N-Gly-Gly + yes [21]
SrtA-M3 LPxTG N-Gly-Gly + yes More DMSO resistent [24]
Sortase mutants with altered specificity
SrtA-F40 APxTG N-Gly-Gly   yes [25]
SrtA-A1-22 APxTG N-Gly-Gly   yes [26]
SrtA-F1-20 FPxTG N-Gly-Gly   yes [26]
eSrtA(4S) LPxSG N-Gly-Gly + + yes engineered on
SrtA-M5 template
[27]
eSrtA(2A) LAxTG N-Gly-Gly + + yes engineered on
SrtA-M5 template
[27]




Sa-SrtA-E105K/E108A LPxTG N-Gly-Gly (  ) no [29]
Sa-SrtA-E105K/E108Q LPxTG N-Gly-Gly (  ) no [29]
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nucleophile in a pseudo-intramolecular reaction, thereby cova-
lently linking the biotin handle to the yeast surface (Fig-
ure 2a).[19] This yeast display system was used to screen a library
of 7.8 × 107 sortase mutants generated by PCR amplification
with mutagenic dNTPs. The screen was aimed primarily at
improving the poor affinity for the sorting motif by adding the
biotin-LPxTG in decreasing concentrations. Upon attachment of
a streptavidin-conjugated fluorophore to the biotin handle, the
yeast cells were subjected to FACS sorting. After several rounds
of selection, SrtA-M4 and SrtA-M5, enzymes carrying 4 and 5
mutations, respectively, were isolated and shown to have a
more than 100-fold higher catalytic efficiency (kcat/KM LPETG)
than wild-type Sa-SrtA (Table 1). The mutations of SrtA–M5 are
located close to the binding groove of the substrate containing
the sorting motif (P94R/D160N/D165A/K196T) and the β7–β8
loop (K190E) interacting with the nucleophile (Figure 2d).[19] The
SrtA-M5 mutant is intensively used in SML approaches and
further protein evolution approaches on the SrtA-M5 scaffold
have been reported.[1a]
A different screening approach was able to evolve further
Sa-SrtA mutants with enhanced kinetics.[20] At first, the wild-
type Sa-SrtA gene was subjected to error prone PCR. In
addition, saturation mutagenesis of the SrtA-M5 template was
used for generating a second sortase library. Both libraries were
Figure 2. Selection schemes for sortase A activity enhancement. a) General scheme for evolving bond-forming enzymes by yeast display as applied to sortase
A. SrtA of S. aureus is displayed as a fusion with the surface protein Aga2p (not shown), which itself is covalently linked to Agap1 (also not shown) carrying the
reactive S6 peptide. Sfp phosphopantetheinyl transferase from Bacillus subtilis is then used to covalently link two glycine residues to the S6 tag, which provide
the nucleophile for the sortase reaction. Biotinylated sorting motif peptide is then ligated to the N-terminal glycine residue by the spatially proximal sortase A
protein, thereby coupling genotype with phenotype. Streptavidin-phycoerythrin is then used to detect and select successfully ligated product by FACS. b) a
FRET-based platform for srtA activity screening. The LPETG sorting motif was fused to the C terminus of EGFP, while a triglycine moiety was attached to the N
terminus of cpVenus. Bacterial clones expressing sortase variants leading to increased FRET signal intensity were selected. c) Protein complementation assay
used for the directed evolution of sortase A. The two fragments of murine dihydrofolate reductase require covalent ligation by SrtA to confer activity and
bacterial survival in the presence of the antibiotic trimethoprim. d) Activity enhancing mutations of SrtA from S. aureus depicted within the solution structure
of the enzyme (PDB ID: 2KID). Mutations found in Chen et al. (2011)[19] are displayed in orange, those found in Chen et al. (2016)[20] in yellow, those from
Suliman et al. (2017) [21] in pink and those from Wojcik et al. (2019)[22] in blue. Amino acids are labeled by type and number with respect to the S. aureus wt
protein, while the corresponding mutations found in the respective screens are indicated behind the number. Residues 59–72 from the structure have been
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screened for high FRET signal intensities resulting from SML of
EGFP and cpVenus equipped with LPETG motif and triglycine
moiety, respectively (Figure 2b). These screens uncovered three
further mutations that enhanced sortase kinetics when com-
bined with the M5 mutations (M5/D124G and M5/Y187L/E189R)
(Figure 2d). These mutants were particularly useful for SML of
antibodies with SrtA-M5/D124G as the most efficient mutant for
ligating peptides to the N terminus of an antibody. SrtA-M5/
Y187E/E189R was highly effective in ligation reactions at the C
termini of antibodies.[20]
A further directed sortase evolution approach was based on
dihydrofolate reductase (DHFR) complementation screens. This
screening platform capitalizes on the assembly of full-length
mammalian DHFR from two fragments extended with LPxTG
and triglycine sequences by SML (Figure 2c). Upon inhibition of
endogenous bacterial DHFR by Trimethoprim, the ligated full-
length murine DHFR becomes essential for bacterial survival.
Screening a library of 2 × 107 sortase mutants generated by
error-prone PCR uncovered five recurrent mutations P94H/
A104T/E105D/G167E/Q172H) localized in the β6–β7 and β7–β8
loops of Sa-SrtA (Figure 2d).[21] P94 is the only common residue
found between two of the screens, supporting the conclusion
that the type and exact conditions of the screening and
selection methods influence the results. More interestingly,
almost all mutations in these different screens change the
charge of the corresponding wild-type amino acid, indicating
that additional long-ranging electrostatic interactions play a
pivotal role in substrate recognition and catalysis. Thus, while
several mutations localize in the vicinity of the substrates,
others are found more remotely at the tip of the β7–β8 loop
(Figure 2d).
Finally, further screening platforms for directed sortase
evolution are currently in development. A recently reported
strategy makes use of immobilized reporters of SML reactions in
microtiter plate formats.[30] SML is used to ligate a reporter
protein to peptides, serving as handles for immobilization. The
reporter protein catalyzes a colorimetric readout reaction when
successfully immobilized in the plates. Screening sortase
libraries obtained by saturation mutagenesis at selected sites
confirmed the efficiency of the M5 mutations for Sa-SrtA
catalysis (Table 1).[30]
3.2. Sortase mutants with altered substrate specificity
In addition to engineering Sa-SrtA kinetics, this enzyme has
been also subjected to directed evolution of substrate
specificity.
Sortases with altered substrate specificity are attractive for
protein semisynthesis approaches where proteins are reconsti-
tuted form synthetic and recombinant fragments by ligation
reactions. Sortases with altered specificity could reduce the
number of mutations that remain as ‘ligation scarring’ with the
ligation products. Furthermore, sortases with alternative sorting
motifs and nucleophile specificities could enable orthogonal
SML with more than two fragments.
Initial attempts to change the Sa-SrtA specificity were based
on the observation that Sa-SrtB recognizes an NPQTN sorting
motif but possesses very limited in vitro activity. Structural data
allowed residues of the β6–β7 loop to be assigned as the main
contact site between sortase and the substrate containing the
sorting motif. A loop-swap chimera (SrtLS) was generated by
grafting the β6–β7 loop of Sa-SrtB onto the Sa-SrtA protein
scaffold.[31] Chimeric SrtLS recognized the NPQTN sequence as
substrate, but was only able to catalyze cleavage of this motif
and not the ligation reaction. A more recently developed Sp-
SrtA chimera was engineered, focusing on altered specificity for
the sortase deacylating peptide nucleophile.[22] Nucleophile
recognition is largely mediated by residues of the β7–β8 loop.
By grafting this region from Sa-SrtA onto Sp-SrtA, the resulting
hybrid enzyme is restricted to N-Gly substrates. The hybrid
enzyme was no longer able to ligate LPxTA motifs to N-Ala
nucleophiles like wild-type Sp-SrtA, confirming the important
role of the β7–β8 loop in nucleophile substrate recognition.
The first directed evolution of Sa-SrtA substrate specificity
was used in a phage display system for selecting mutants with
altered sorting motif specificity. A library of 1 × 108 Sa-SrtA
mutants was generated by NNK mutagenesis, randomizing six
residues of the β6–β7 loop predicted to interact with the
leucine residue of the LPxTG motif (Figure 3a).[25] The library was
displayed as C-terminal fusion with the pIII surface protein on
M13 phages. The N terminus of the displayed sortase mutants
was extended by a pentaglycine tail, enabling ligations to the N
termini. Ligation of biotinylated LPxTG peptides allowed enrich-
ment of phages on streptavidin resins. After three rounds of
phage display with a biotin-FPxTG bait, isolated sortase mutants
were characterized. In general, these mutants were promiscu-
ous with respect to the leucine position in the sorting motif and
ligated the expected FPxTG sequence. The activity of the
selected mutants was generally lower than that of the wild-type
enzyme. One mutant, referred to as F40 sortase, appeared
particularly interesting because this enzyme catalyzed ligation
reactions of APxTG and DPxTG substrates. The first of these
amino acid sequences is present in histone H3, enabling
traceless semisynthesis of this protein by SML.[25] However, the
general broadening of specificity in this phage display
campaign was surprising and further investigated. The initial
library design was based on the first reported Sa-SrtA crystal
structure.[32] However, the subsequently elucidated NMR struc-
ture of the sortase A construct with covalently attached LPA
core motif analog revealed a very different conformation of the
β6–β7 loop in the substrate bound state, indicating that the
residues selected for randomization might not have been ideal
for evolving the Sa-SrtA specificity.[33] This NMR structure could
retrospectively rationalize the preference of Ala and Asp instead
of Leu at the first position of the sorting motif, despite the
ligation reaction having been performed with an FPKTG
peptide. A more bulky Met residue is found instead of Val at
position 168 of the β6–β7 loop in the F40 sortase, likely to
geometrically favor small side-chains in the substrate. In
addition, R197 of the β7–β8 loop likely provides a favorable
charge interaction in case the N-terminal residue of the sorting
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β6–β7 loop, a re-designed Sa-SrtA library was generated, based
on the NMR Sa-SrtA structure using trinucleotide building
blocks, and also including variations of the β6–β7 loop
length.[26] Phage display screening of this re-designed library
with FPxTG and APxTG baits yielded sortase mutants SrtA-F1-20
and SrtA-A1-22 with expected preferences for these altered
sorting motifs. The majority of isolated mutants contained β6–
β7 loops that were longer than the native loop (11 instead of
nine residues; Figure 3b).[26]
A set of orthogonal sortases recognizing LAxTG and LPxSG
motifs evolved on the basis of the yeast display system
discussed above (Figure 2a) was reported, enabling dual label-
ing of proteins with SML. The screening campaign of a sortase
library at 2 % mutation level was optimized for high selectivity,
and yielded sortase mutants with the desired altered specificity
and no significant loss in activity.[27] Three key mutations
responsible for substrate promiscuity were derived from this
screen and used to generate sortase mutants accepting LAxTG
and LPxSG as sorting motifs. These mutants were subjected to
further directed evolutions, finally delivering evolved sortases
eSrtA(2A) and eSrtA(4S) showing high specificity for LAxTG and
LPxSG motifs. Both enzymes accumulated a significant number
of mutations during the evolution process, some of which were
located at contact sites between the enzyme and the substrate,
while other mutations were found in remote regions (Figure 3c).
Importantly, these mutants maintained a high increase in
activity (Table 1).[27]
3.3. Calcium-independent sortase mutants and mutants with
improved solvent or temperature stability
A further challenge of Sa-SrtA is the requirement of calcium for
effective catalysis. Calcium-dependency constitutes a significant
problem for applications in living cells where calcium levels are
low. Calcium-dependency is observed mainly for sortases of
Figure 3. Sortase mutants with altered substrate specificity. a) Selection scheme for changing the specificity of SrtA. Self-ligation of an altered sorting motif to
the N-terminal glycine artificially fused to the randomized sortases displayed on phage allows active sortases to be labeled by biotin and subsequent
enrichment on NeutrAvidin-coated agarose beads. The design of the first-generation SrtA library is shown below left and indicates the six NNK randomized
positions in orange. The second-generation library was randomized at positions 161–169 by using trinucleotides and excluding stop and cysteine codons.
Furthermore, loop lengths were allowed to vary between 7 and 11 amino acids. The most potent variant indeed contained 11 amino acids, as indicated
bottom right. b) Altering sortase A specificity and calcium dependence by design. The amino acids of SrtA that were randomized or changed by design are
rendered as sticks. Libraries selected for the recognition of amino acids other than leucine at the first position of the sorting motif are shown in orange with
the randomized region restricted to the β6–β7 loop, see (a) for the identified mutations. Amino acids are indicated by type and number and the core LPA
motif of the ligand is displayed in green. The two mutations that were rationally designed to render SrtA Ca2+-independent are shown in purple. The bound
calcium is displayed as a gray sphere. c) Mutations identified by full randomization of SrtA and selected to ligate the sorting motif LAETG are shown in blue.
As in (b) amino acids that were found to be mutated compared to wt sortase A from S. aureus are rendered as sticks (in blue). In the screen performed in this
study,[20] randomization started from sortase A with enhanced kinetic properties (the so-called M5 variant or eSrtA, Figure 2d), thus two of the mutations,
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Staphylococci origin, while other sortases, including Sp-SrtA, are
calcium-independent. However, since Sa-SrtA is the most active
sortase uncovered so far, a calcium-independent enzyme was
generated by rational design.[29] In Sa-SrtA, the Ca2 + ion is
important for stabilizing the closed conformation of the β6–β7
loop in a substrate-bound state. The Ca2 + binding site is formed
by three glutamic acid residues: Glu171 of the β6–β7 loop, and
Glu 108 and Glu 105 located in the β3–β4 loop. In the calcium-
independent Sp-SrtA, the Ca2 + interactions are substituted by a
salt bridge between a lysine and an aspartic acid moiety. The
calcium-independent Sa-SrtA was generated by installing a
similar salt bridge into the β3–β4 loop. The resulting mutants,
Sa-SrtA(E105K/E108A) and Sa-SrtA(E105K/E108Q), catalyzed SML
reactions with slightly slower kinetics compared to the wild-
type enzyme in the absence of calcium. Mutations mediating
calcium independence could be further combined with the
rate-accelerating mutations of the SrtM5 enzyme.[34] The
resulting SrtA-M7 combines the advantageous features of both
engineering approaches and is now a widely used tool in
protein chemistry.[23] The SrtA-M7 enzyme was further shown to
accept a broad range of small molecule amine nucleophiles
containing biorthogonal groups. When co-expressing SrtA-M7
and LPxTG containing proteins in Escherichia coli this feature
was exploited for the in vivo incorporation of alkynes, azides
and tetrazines into the co-expressed proteins.[35]
A further desirable feature of enzymes used for biotechnol-
ogy is their resistance to organic solvents. SML in organic
solvents or mixtures of water and organic solvents would allow
ligation reactions with hydrophobic substrates. Wild-type
sortase activity decreases dramatically in the presence of high
concentrations of solvents like DMSO. An engineering campaign
screened for sortase mutants able to perform SML in the
presence of 45 % DMSO. The screen was based on ligation of a
LPxTG modified CueO laccase reporter to an N-Gly modified
anchoring protein, enabling immobilization of the ligation
products in polypropylene microtiter plates. A sortase library
generated by saturation mutagenesis was screened in the
presence of 45 % DMSO for efficient SML. The screen delivered
sortase mutants, including SrtA-M3, which showed higher
transpeptidase activity than wild type Sa-SrtA in both the
presence and absence of 45 % DMSO.[24]
To improve the thermostability of Sa-SrtA, multiple se-
quence alignments of sortases revealed certain positions of
sortases from extremophiles to be conserved or distinct from
Sa-SrtA, identifying M155V and V193R as mutations that
increased activity at 37 °C or higher (Figure 2d; Table 1).[36]
Notably, sortases evolved for high catalytic activity com-
monly come at the cost of decreased thermostability. It was
therefore attempted to improve the stability of the activity-
enhanced M4 mutant from the original yeast display screen
(Table 1).[19,37] This mutant shows a more than 10 °C lower
thermal melting temperature compared to wild-type SaSrtA
(48.6 vs 59.4 °C). Single site-saturation mutagenesis of residues
in the β6–β7 loop identified two mutations (R159N and K162P)
that, when combined, led to a 6 °C higher stability of this new
M6-SrtA. The relative activity of the M6 mutant was increased
58-fold compared to wild-type SaSrtA after pre-incubation of
the enzymes at 55 °C for 1 hour. Further improvement of
stability by 1.5 °C was achieved by head-to-tail cyclization of the
engineered variant.[37]
4. Applications of Engineered Sortases
Engineered sortases have already made a strong impact on
protein chemistry. In particular, SrtA-M5 and the calcium-
independent SrtA-M7 with enhanced kinetics are often used as
more efficient alternatives to wild-type Sa-SrtA. Biotechnolog-
ical approaches, such as the generation of antibody conjugates
with biophysical probes or drugs by SML, benefit strongly from
the accelerated ligation reactions catalyzed by these
enzymes.[1a,f]
Here we will focus on biochemical applications of engi-
neered sortases, particularly the utility of these enzymes for
investigating the function of post-translational modifications
(PTMs) of proteins. We will refer to other reviews for a more
global view on sortase applications.[1]
PTMs can serve as regulators of protein function and activity
by modulating protein-protein interactions or inducing con-
formational changes within the protein structure.[38] Histone
proteins package eukaryotic DNA into chromatin and are
extensively decorated by PTMs in the N-terminal tail regions.[39]
These histone tails protrude from the basic structural units of
chromatin, the nucleosomes, into the nucleus.[40] Modifications
of histone tails constitute an epigenetic histone code by
recruiting chromatin factors to the DNA template. Protein
semisynthesis is an attractive tool for generating histones with
defined modification patterns. In the first step, PTMs are
introduced into the synthetic fragments and a subsequent
ligation reaction introduces the modification into the full-length
protein.[39] SML is particularly useful for generating semisyn-
thetic histone H3. Histone H3 contains the sequence APATG at
the interface between the tail and the globular fold, spanning
positions 29 to 33, which resembles the LPxTG sorting motif
closely. Wild-type sortase has been used for generating libraries
of nucleosomes with defined methylation and phosphorylation
patterns.[41] The H3 tails were installed on the level of assembled
nucleosomes and allowed the generation of libraries with
defined modification patterns. Library screens with chromatin
reader protein HP1 uncovered a cross-talk between the HP1
recruitment site at H3K9me2 and phosphorylation of the
remote residue S28, thereby demonstrating the utility of SML
for chromatin research.[41]
However, SML of H3 with wild-type Sa-SrtA comes at the
price of an A29L point mutation introduced into H3, which
could potentially impact the native interactions between
chromatin factors and the histone tail. The F40 sortase mutant
represents an alternative catalyst for H3 SML, despite being less
active than wild-type Sa-SrtA. Ligation of the native H3
sequence APATG by F40-SrtA allows traceless H3 semisynthesis
and has already been applied in chromatin biochemistry.[25] The
SAGA complex is a transcriptional coactivator and possesses
lysine acetyltransferase activity.[42] It was shown that SAGA is
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by a tandem Tudor domain with SAGA protein Sgf29. H3K4me3
nucleosomes were generated by F40-SrtA catalyzed SML of H3
from a synthetic H3K4me3 peptide and N-terminal truncated
recombinant H3.[43] In contrast to the library approach discussed
above, this SML reaction was performed on the histone level,
and the ligated H3 was subsequently incorporated into
reconstituted nucleosomes. In a competitive setting of
H3K4me3 nucleosomes in the presence of unmodified nucleo-
somes, SAGA preferentially hyperacetylated the H3K4me3
fraction, allowing a model to be established for the recruitment
of the SAGA complex to chromosomal promoter regions.[43]
In addition to lysine acetyltransferases, their counterparts,
lysine or histone deacetylases (HDACs) constitute a further
important class of transcriptional regulators. The CoREST
complex plays a central role in neuronal development and
possesses deacetylase activity, mediated by HDAC1. In addition,
the complex contains LSD1, a histone demethylase of
H3K4me2.[44] HDAC1 and LSD1 are tethered by scaffolding
protein CoREST, forming the complex core referred to as LHC.
The catalytic properties and regulation of LHC were character-
ized using nucleosomes modified at H3 with methylation marks
at K4 and further acetylated lysine residues at the K9, K14, and
K18 positions.[45] Modified H3 was generated by SML with F40
sortase and subsequently incorporated into nucleosomes
(Figure4 a). The SML reaction involved sorting motif substrates
with a depsipeptide bond downstream of the threonine residue
in the sorting motif. The released leaving group contains an N-
terminal glycolic acid moiety, which does not compete with the
N-Gly nucleophile of truncated H3, thus driving the SML
reaction to completion.[8a] This strategy was also applied for
establishing nucleosomal libraries with wild type Sa-SrtA as
discussed above. The site-specifically methylated and acetylated
nucleosomes showed that H3K14ac suppresses demethylation
of H3K4me2 by LSD1. Furthermore, HDAC1 removes the
H3K14ac mark sluggishly compared to acetylation marks at
H3K9ac and H3K18ac. These observations indicate a regulatory
crosstalk between H3K4me2 and H3K14ac.[45] The SML strategy
was further applied for generating H3-acetylated nucleosomes
for investigating further complexes containing class I HDACs
including CoREST, NuRD, Sin3B, MiDAC, and SMART.[46] Deacety-
lation experiments showed variations in substrate specificities
of these complexes and a glycine residue upstream of H3K14ac
that induces reduced deacetylase activity of CoREST towards
this acetylation mark.[47]
Ubiquitylation and SUMOylation are two further important
PTMs of proteins.[48] These small proteins are linked to lysine
side chains via isopeptide bonds. Several elaborate ligation
strategies have been developed for site-specific ubiquitylation
and SUMOylation of proteins.[49] A recently reported strategy,
referred to as “sortylation”, combines genetic-code expansion
and SML with engineered sortases enabling ubiquitylation and
SUMOylation in living cells (Figure 4b).[28] This approach was
made possible by genetic encoding of lysine carrying an azido-
Gly-Gly isopeptide extension using amber suppression technol-
ogy. Upon incorporation into recombinant proteins, the azide
can be reduced to an amine to serve as a nucleophile in SML
reactions. To this end, the LPxTG motif was engineered into the
C terminus of ubiquitin or SUMO, allowing their ligation with
SrtA-M5. However, the inserted proline residue yielded an
undesirable outcome and was substituted with an alanine
residue, resulting in an LAxTG motif serving as substrate of
engineered eSrtA(2A). The resulting ubiquitylated proteins differ
at two positions from the native amino acid sequence, and the
isopeptide bond was shown to be resistant to deubiquitinases.
This methodology could be further established in living cells by
coexpression of all reaction partners. However, in order to cope
with the low intracellular calcium concentration, the eSrtA(2A)
enzyme was subjected to a further engineering step, introduc-
ing the D105H and E108E mutations to render the resulting
mStrt2A calcium-independent. The mSrt2A enzyme allowed
Figure 4. Applications of engineered sortases. a) Engineered F40 sortase allows traceless semi-synthesis of histone H3. Highly efficient SML of H3 was enabled
by inserting a depsipeptide bond into the sorting motif. Designer nucleosomes site-specifically methylated and acetylated at Lys4 and Lys14 allowed
mechanistic insights into the recognition of the LHC core of the CoREST complex. b) Genetic encoding of a lysine residue with isopeptide azido-Gly-Gly
modification allowed in vivo installation of ubiquitin by engineered mSrt2A. Reduction of the azido moiety delivered the amine nucleophile, which was
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application of this methodology in live cells, thus bypassing the
native ubiquitylation and SUMOylation systems.[28]
These recent examples of SML with engineered sortases
provide a first glimpse at the potential of these tools for
investigating protein modifications. With more engineered
sortases providing new features, it appears likely that the
impact of SML on modern biochemistry will continue to evolve.
5. Summary and Outlook
Sortase engineering has come of age, showing that wild-type
sortase can be improved with regard to its catalytic activity and
that its specificity can be changed with regard to individual
positions in the sorting motif. This allows for interesting
applications in the field of intracellular signaling, probing the
role of individual post-translational modification events. Capital-
izing on the already established set of engineered sortases
allows researchers to create sortases with new properties by
combining structurally independent elements of the enzyme
(e. g., the incorporation of kinetically derived mutants into
specificity changing mutants). Alternatively, future research may
exploit the richness of natural sortases by methods such as
DNA shuffling, with the promise to further explore sequence
space and to direct evolution towards new substrate specific-
ities. These attempts are ideally flanked by mechanistic
investigations that capture the essential dynamics and struc-
tural transitions that accompany the two ligation steps. Based
on its ease of expression and manipulation, sortase A might
become a good example of how to stretch the limits of a
naturally occurring enzyme for the purpose of biotechnology.
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